MENU
BCLI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Brainstorm Cell Therapeutics (BCLI) Ownership - Who owns Brainstorm Cell Therapeutics?
Industry: @Computer Peripherals
Profile
Industry
Computer Peripherals
Address
1325 Avenue of Americas
Phone
+1 201 488-0460
Employees
29
Web
https://www.brainstorm-cell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.21M
P/E Ratio
N/A
Total Cash
168K
Projected Growth
N/A
Total Debt
841K
Revenue
N/A
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash/Share
0.03
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BCLI
Capitalization
10.2M
P/E Ratio
N/A
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash
168K
Total Cash/Share
0.03
Total Debt
841K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-6.06M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-3.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14K
Current Ratio
0.05
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-13.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
10.00
Revenue To Assets
-369.22
Shares Held By Institutions
4.54M
Shares Outstanding - Current
5.7M
Total Liabilities
8.08M
Total Volume MTD
N/A
Value
-1
Gain YTD
-56.288
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company, which develops innovative adult stem cell therapeutic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
1325 Avenue of Americas
Phone
+1 201 488-0460
Employees
29
Web
https://www.brainstorm-cell.com